Anaphylactoid reaction from amifostine

Radiotherapy and Oncology

Volumn 82, Issue 1, 2007, Pages 110-111

  Rolleman, Edgar J ^a   Forrer, Flavio ^a   Deckers, Jaap ^a   de Groot, Hans ^b   Valkema, Roelf ^a   de Jong, Marion ^a   Krenning, Eric P ^a  

^a Department of Nuclear Medicine ^*

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE;

ANAPHYLAXIS; CHEST TIGHTNESS; CORONARY ARTERY BLOOD FLOW; DRUG EFFICACY; DYSPNEA; HEART INFARCTION; HUMAN; HYPOTENSION; HYPOXIA; LETTER; LUNG EMBOLISM; PRIORITY JOURNAL; RADIATION PROTECTION; RASH;

AMIFOSTINE; DIAGNOSIS, DIFFERENTIAL; HUMANS; MYOCARDIAL ISCHEMIA; PURPURA, SCHOENLEIN-HENOCH; RADIATION-PROTECTIVE AGENTS;

EID: 33846295521     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.10.024     Document Type: Letter

References (5)

1. Lin A., and Lawrence T.S. An anaphylactoid reaction from amifostine. Radiother Oncol 79 (2006) 352
2. Brizel D.M., and Overgaard J. Does amifostine have a role in chemoradiation treatment?. Lancet Oncol 4 (2003) 378-381
3. Sasse A.D., Clark L.G., Sasse E.C., and Clark O.A. Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis. Int J Radiat Oncol Biol Phys 64 (2006) 784-791
4. Vardy J., Wong E., Izard M., Clifford A., and Clarke S.J. Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review. Anticancer Drugs 13 (2002) 327-330
5. Buentzel J., Micke O., Adamietz L.A., Monnier A., Glatzel M., and de Vries A. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study. Int J Radiat Oncol Biol Phys 64 (2006) 684-691